Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study

BACKGROUND: The long-acting β(2)-agonist (LABA) formoterol has an onset of effect comparable to that of salbutamol. Consequently, the combination of formoterol and budesonide in one inhaler, approved for maintenance use, can potentially be used for reliever therapy. This study compared the onset of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jonkers, René E, Bantje, Theo A, Aalbers, René
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1713239/
https://www.ncbi.nlm.nih.gov/pubmed/17144916
http://dx.doi.org/10.1186/1465-9921-7-141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1713239/
https://www.ncbi.nlm.nih.gov/pubmed/17144916
http://dx.doi.org/10.1186/1465-9921-7-141

Ejemplares similares